0.02
+(+%)
Currency In USD
Address
3350 W Bayshore Rd.
Palo Alto, CA 94303
United States of America
Phone
650-549-9103
Website
Sector
Healthcare
Industry
Biotechnology
Employees
6
First IPO Date
March 15, 2021
| Name | Title | Pay | Year Born |
| Ms. Divya Patel CPA | Acting Chief Financial Officer | 100,000 | 1990 |
| Dr. Satyajit Mitra Ph.D. | Head of Oncology & Executive Director | 225,000 | 1974 |
| Dr. Hoyoung Huh M.D., Ph.D. | Executive Chairman | 659,000 | 1969 |
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.